Fierce Pharma

SEPTEMBER 28, 2023

Fabre-Kramer Pharmaceuticals' major depressive disorder (MDD) drug gepirone has been rejected by the FDA not once, not twice, but three times since the turn of the millennium. | Fabre-Kramer's Exxua suffered three prior FDA rejections before scoring an FDA approval for major depressive disorder last week. Its label doesn't include sexual dysfunction as an adverse reaction, which is rare among antidepressants.

FDA 305

FDA Pharmaceutical 305

MedCity News

SEPTEMBER 28, 2023

Sanofi dominates the market for therapies that treat Pompe disease, a rare enzyme deficiency. The FDA has approved an Amicus Therapeutics combination treatment for patients inadequately served by the Sanofi products.

FDA 122

FDA Marketing Patients Biopharma 122

Fierce Pharma

SEPTEMBER 28, 2023

Slated for an FDA decision last October, Amicus Therapeutics’ Pompe disease bid was foiled by COVID-related travel restrictions. | Slated for an FDA decision last October, Amicus Therapeutics’ Pompe disease bid was foiled by COVID-related travel restrictions. Nearly a year later, the Philadelphia company has gained its long-awaited green light.

FDA 272

FDA 272

MedCity News

SEPTEMBER 28, 2023

New York, Florida, Texas and Minnesota terminated Medicaid coverage for some enrollees for “unallowable or potentially unallowable reasons” during the Covid-19 public health emergency, according to a recent Office of Inspector General report.

120

120

Advertisement

Distribution

Fierce Pharma

SEPTEMBER 28, 2023

While GLP-1 drugs from Novo Nordisk and Eli Lilly are believed to be relatively free of serious side effects, a few problems have emerged as the treatments have gained wider and longer-term use.

Side effects 269

Side effects FDA 269

MedCity News

SEPTEMBER 28, 2023

C-SNPs are Medicare Advantage plans formulated to meet the desired needs of people living with chronic diseases. These plans are different from traditional Medicare plans because they’re only available to people who fit the special needs category that the plan serves.

Healthcare 111

Healthcare Healthcare Specialization Management 111

Copyright Clearance Center

SEPTEMBER 28, 2023

September 28, 2023 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, announces the availability of AI-disambiguated data and enriched metadata, for researchers and institutions, within RightFind Navigate through a pilot for its customers. CCC also announces several powerful new features of the RightFind Suite.

Management 111

Management Pharmaceutical 111

Fierce Pharma

SEPTEMBER 28, 2023

A highly anticipated head-to-head matchup between a Johnson & Johnson combination and AstraZeneca’s star Tagrisso as a first-line treatment in a subset of non-small cell lung cancer (NSCLC) has | With the trial win, Johnson & Johnson sees potential for its drug combination as the new standard of care in locally advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer.

232

232

Integrity Solutions

SEPTEMBER 28, 2023

It’s never been more important to understand your customers and what they value. It’s easy to say that we put the customer first, but what does that actually look like in practice? In the past, customer service centers were viewed as cost centers or expenses. Today, the organizations that are delivering a superior customer experience are proving just how outdated that perspective is.

Training 110

Training Sales Management Product Knowledge 110

Fierce Pharma

SEPTEMBER 28, 2023

Riding on the growth of long-acting antiretroviral therapy Cabenuva, GSK is laying out a more optimistic vision for its overall HIV business. | Riding on the growth of long-acting antiretroviral therapy Cabenuva, GSK is laying out a more optimistic vision for its overall HIV business.

Sales 214

Sales 214

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

Pharmaceutical Technology

SEPTEMBER 28, 2023

The company’s algorithms put proteins through millions of years of simulated evolution to identify potential functional candidates.

126

126

Fierce Pharma

SEPTEMBER 28, 2023

As bluebird bio’s pricey gene therapy launches take flight, the company is boosting manufacturing capacity with Swiss CDMO Lonza. | Bluebird and Lonza recently amended their production contract for the second time since the deal was announced in summer of 2016. Under the updated deal, Lonza has agreed to increase manufacturing capacity for bluebird’s therapies Zynteglo and Skysona, according to a SEC filing published Wednesday.

Manufacturing 210

Manufacturing 210

MedCity News

SEPTEMBER 28, 2023

Through a new partnership, Vori Health will be able to refer its patients who report having an opioid addiction to Ophelia. On the flip side, Ophelia can refer its patients who report having MSK pain to Vori Health for non-opioid treatment.

Patients 104

Patients 104

Fierce Pharma

SEPTEMBER 28, 2023

AstraZeneca has made several news headlines for its environmental sustainability pledges, including deals for renewable natural gas and a commitment to plant hundreds of millions of trees. | In this episode of "The Top Line," Fierce Pharma's Eric Sagonowksy talks with Pam Cheng, the AstraZeneca executive who is playing a key role in driving the company's sustainability ambitions.

Pharma 202

Pharma 202

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

PharmaTech

SEPTEMBER 28, 2023

Dosage forms are being shaped by numerous factors, with patient-centricity continuing to be an important driver of decisions in development.

Patients 116

Patients 116

Fierce Pharma

SEPTEMBER 28, 2023

The FDA has signed off on Takeda’s subcutaneous version of Entyvio to be used as a maintenance therapy for patients with ulcerative colitis.

FDA 211

FDA Patients 211

PharmaTimes

SEPTEMBER 28, 2023

Collaboration will enable teams across the organisation to increase clinical research innovation - News - PharmaTimes

122

122

Fierce Pharma

SEPTEMBER 28, 2023

Dato-DXd, the TROP2-targeted antibody-drug conjugate in development by AstraZeneca and Daiichi Sankyo, has hits its goal in a breast cancer trial. | AstraZeneca and Daiichi Sankyo's TROP2-targeted antibody-drug conjugate has hits its goal in a breast cancer trial. The combination of Padcev and Keytruda also succeeded in a broad first-line bladder cancer setting.

Pharma 130

Pharma 130

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

European Pharmaceutical Review

SEPTEMBER 28, 2023

According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), more than 600 essential medicines are at risk if a proposed restriction on the use of fluorinated substances, per- and polyfluoroalkyl substances (PFAS) across pharmaceutical manufacturing in the EEA, is implemented. A total ban [of PFAS] would see medicines’ manufacturing in the EU grind to a halt in under three years” EFPIA stated that the EU chemical legislation under The Regulation on the regist

Pharmaceutical manufacturing 97

Pharmaceutical manufacturing Manufacturing Pharmaceutical Medicine 97

PharmaTimes

SEPTEMBER 28, 2023

Initiative has been designed to support career advancement for women across the life sciences - News - PharmaTimes

116

116

MedCity News

SEPTEMBER 28, 2023

For the September episode, we discuss some recent executive appointments occurring in the healthcare sector, as well as layoffs affecting the industry. We also hear from Chris Allen, who recently became CFO at Keck Medicine of USC.

Medicine 88

Medicine Healthcare Healthcare 88

Pharmaceutical Commerce

SEPTEMBER 28, 2023

Questions and considerations for pharmaceutical companies in designing and executing strategies to curb the incidence of fake drugs.

Pharmaceutical 105

Pharmaceutical 105

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

European Pharmaceutical Review

SEPTEMBER 28, 2023

There has been a steady stream of developments in the vaccine manufacturing space throughout 2023. A notable milestone was Moderna’s announcement in April that it had, following finalisation of a ten-year strategic partnership with the UK Government, commenced construction of its mRNA vaccine manufacturing technology centre. Known as MITC, or the Moderna Innovation and Technology Centre, the facility is located in Harwell, Oxfordshire and is expected to become operational in 2025.

Manufacturing 85

Manufacturing Government Pharmaceutical manufacturing Pharmaceutical 85

PharmaVoice

SEPTEMBER 28, 2023

A recent report showed how pharma’s bonuses pale in comparison to other industries, but several execs still rake in hefty packages.

Pharma 95

Pharma 95

Pharmaceutical Commerce

SEPTEMBER 28, 2023

How recent advancements in practice and technology have ushered in a new era of pharmaceutical logistics.

Pharmaceutical 104

Pharmaceutical 104

MedCity News

SEPTEMBER 28, 2023

Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.

Healthcare 88

Healthcare Healthcare Medicine Pharmaceutical 88

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

PharmExec

SEPTEMBER 28, 2023

Lakdawalla speaks about how drugs aren’t being properly valued.

110

110

PharmaVoice

SEPTEMBER 28, 2023

As Medicare negotiations heat up, it’s more important than ever for pharma companies to communicate their value. Here’s how.

Pharma 72

Pharma Marketing 72

MedTechVets

SEPTEMBER 28, 2023

SEP 28th – We were proud to interview MedTechVet Academy Mentor, Grant Cox. Grant is currently the Vice President of Operations at Z Construction. He recently was going through the Fire Academy in Greenville, SC to become a Firefighter, but was medically released after having surgery on both of his hips.Grant is a huge believer in medicine and believes that better days are ahead of him. “With strong faith, a goal in mind and a purpose, you can get through anything.

Medical 59

Medical Specialization Recruitment Networking 59

PharmaTech

SEPTEMBER 28, 2023

The ROSS line of Dual Shaft Mixers are robust, versatile systems with enough power to batch dispersions, suspensions, and emulsions with viscosities up to several hundred thousand centipoise.

52

52

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management